Featured readings on HTA and Reimbursement Systems


Share this...
Tweet about this on TwitterShare on FacebookShare on LinkedInEmail this to someoneShare on Google+Share on RedditPin on Pinterest

Corinna Sorenson, Michael Drummond, Panos Kanavos (2008) Ensuring value for money in health care - The role of health technology assessment in the European Union, Political Science, p. 179, pdf, doi:doi:10.1001/jama.2009.984

Kristian Lampe, Marjukka Mäkelä, Marcial Velasco Garrido, Heidi Anttila, Ilona Autti-Rämö, Nicholas J. Hicks, Björn Hofmann, Juha Koivisto, Regina Kunz, Pia Kärki, Antti Malmivaara, Kersti Meiesaar, Päivi Reiman-Möttönen, Inger Norderhaug, Iris Pasternack, Alberto Ruano-Ravina, Pirjo Räsänen, Ulla Saalasti-Koskinen, Samuli I. Saarni, Laura Walin, Finn Børlum Kristensen (2009) The HTA Core Model: A novel method for producing and reporting health technology assessments, International Journal of Technology Assessment in Health Care 25(S2), p. 9-20, url, doi:10.1017/S0266462309990638

Iris Pasternack, Heidi Anttila, Marjukka Mäkelä, Tuija Ikonen, Pirjo Räsänen, Kristian Lampe, Hans van Brabandt, Irina Cleemput, Chris de Laet, Marco Marchetti, Pietro Refolo, Dario Sacchini, Regina Kunz, Alain Nordmann, Dagmar Lühmann, Bo Freyschuss (2009) Testing the HTA core model: experiences from two pilot projects., International journal of technology assessment in health care 25 Suppl 2(2), p. 21-7, pubmed, doi:10.1017/S026646230999064X

Corinna Sorenson (2009) The role of HTA in coverage and pricing decisions: a cross-country comparison, European Observatory on Health Systems and Policies 11(1), url

Tania Stafinski, Devidas Menon, Caroline Davis, Christopher McCabe (2011) Role of centralized review processes for making reimbursement decisions on new health technologies in Europe, ClinicoEconomics and Outcomes Research 3(1), p. 117-186, pdf, doi:10.2147/CEOR.S14407

A. Towse, N. Devlin, E. Hawe, L. Garrison (2011) The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response, Office of Health Economics(January), url

Louis P. Garrison, Adrian Towse, Andrew Briggs, Gerard De Pouvourville, Jens Grueger, Penny E. Mohr, J. L. Severens, Paolo Siviero, Miguel Sleeper (2013) Performance-based risk-sharing arrangements - Good practices for design, implementation, and evaluation: Report of the ISPOR good practices for performance-based risk-sharing arrangements task force, Value in Health 16(5), p. 703-719, url, doi:10.1016/j.jval.2013.04.011

Louis P. Garrison (2016) Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview, Value in Health 19(5), p. 512-515, pdf, doi:10.1016/j.jval.2016.04.018

Zoltán Kaló, Adrian Gheorghe, Mirjana Huic, Marcell Csanádi, Finn Boerlum Kristensen (2016) HTA Implementation Roadmap in Central and Eastern European Countries, Health Economics (United Kingdom) 25, p. 179-192, url, doi:10.1002/hec.3298

Tara Cowling, Sirjana Pant (2016) Single Drug Technology Assessment Processes Across Health Technology Assessment Organizations, CADTH, pdf

Evelien Moorkens, Arnold G Vulto, Isabelle Huys, Pieter Dylst, Brian Godman, Simon Keuerleber, Barbara Claus () Policies for biosimilar uptake in Europe: An overview, PLoS ONE, url, doi:10.1371/journal.pone.0190147

EUnetHTA (2017) Annex 1: Agency data. An analysis of HTA and reimbursement procedures in EUnetHTA partner countries: final report., EUNETHTA, p. 1-46, url

Ronald L. Akehurst, Eric Abadie, Noël Renaudin, François Sarkozy (2017) Variation in Health Technology Assessment and Reimbursement Processes in Europe, Value in Health 20(1), p. 67-76, pdf, doi:10.1016/j.jval.2016.08.725